Paul L. Berns, 10% Owner: Lyell Immunopharma LYEL Buy · Filed 03/09

Trade details

Type: Insider buy
Amount: $12,499,984.9
Shares · price: 488,090 sh · $25.61 a share
Held after: 1,426,528 sh
Stock: Lyell Immunopharma LYEL
Person: Paul L. Berns10% Owner
Trade date: 26/03/06
Filed: 26/03/09
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 14 insiders
Holding change: +52.0%

Lyell Immunopharma trades, last 26 weeks

What else happened in Lyell Immunopharma around then

Filed or reported within 30 days of the trade day · 02/04~04/05

Paul L. Berns's recent trades

Paul L. BernsDirector
BuyKardigan
Buy
Kardigan
KARD
$20M
1,250,000 sh
$20M
Filed 06/24
Traded 06/22
Paul L. BernsSEE REMARKS
SellNeumora Therapeutics
Sell
Neumora Therapeutics
NMRA
$34.5K
9,819 sh
$34.5K
Filed 02/19
Traded 02/17
Paul L. BernsOfficer
Planned saleNeumora Therapeutics
Planned sale
Neumora Therapeutics
NMRA
$34.5K
9,819 sh
$34.5K
Filed 02/17
Traded 02/17
Paul L. BernsSEE REMARKS
Sell10b5-1 planNeumora Therapeutics
Sell10b5-1 plan
Neumora Therapeutics
NMRA
$23.4K
13,871 sh
$23.4K
Filed 25/02/20
Traded 25/02/18
Paul L. BernsOfficer
Planned sale10b5-1 planNeumora Therapeutics
Planned sale10b5-1 plan
Neumora Therapeutics
NMRA
$23.5K
13,871 sh
$23.5K
Filed 25/02/18
Traded 25/02/18